Licensing Royalties

Patent royalties can be structured in several ways depending on the parties' business goals: RUNNING ROYALTY (MOST COMMON): royalty calculated on an ongoing basis tied to usage; TYPES: (a) percentage of net sales (most common in pharma, consumer goods, technology): percentage × net sales revenue; net sales = gross sales minus returns, discounts, allowances; typically 1-15% of net sales depending on industry; (b) per-unit royalty: fixed dollar amount × number of units sold; simpler calculation; avoids disputes over net sales deductions; common in hardware, manufacturing; (c) per-transaction royalty: common for software (per download, per user, per API call); LUMP-SUM PAYMENT: one-time payment for the entire license term; no ongoing royalty administration; licensor accepts risk of under-valuing; licensee accepts certainty; often negotiated as a function of projected usage; MILESTONE PAYMENTS: common in pharma/biotech licensing; payments triggered by specific events: IND filing; Phase II completion; FDA approval; first commercial sale; typically combined with running royalties; MINIMUM ANNUAL ROYALTIES: guarantee a minimum payment regardless of actual usage; protects licensor if licensee underperforms; if minimums not met, licensor may get termination right; HYBRID STRUCTURES: upfront license fee + running royalty; reduces licensor's front-end risk while maintaining upside; common for early-stage technology licensing; SUBLICENSING FEES: if the licensee can sublicense, the head licensor typically gets a percentage (often 25-50%) of sublicense income; MILESTONE + RUNNING + SUBLICENSE: common in university technology transfer and pharma licensing.

Royalty rates vary significantly by industry based on technology value, margins, and market norms: PHARMACEUTICAL AND BIOTECH: branded drugs: 4-10% of net sales; biologic drugs: 3-8%; medical devices: 3-7%; early stage (pre-IND): 3-5%; post-Phase II: 6-12%; university licenses: often 3-8% + milestones; RATIONALE: high development costs; long exclusivity periods; high margins justify higher rates; SOFTWARE AND TECHNOLOGY: enterprise software: 5-15%; consumer software: 2-7%; SaaS/cloud: revenue share 10-25% or per-seat fees; mobile apps: 5-20% (highly variable); RATIONALE: high value-add; scalable; patent often core to entire product; CONSUMER PRODUCTS: branded consumer goods: 2-5% of net sales; industrial consumer goods: 1-3%; commodity products: 0.5-2%; ELECTRONICS AND SEMICONDUCTORS: standard-essential patents (SEPs): 0.1-1% per patent family (FRAND rate); component patents: 0.5-3% of component price; system-level patents: 1-4% of product price; RATIONALE: royalty stacking a concern (many patents per product); SEP FRAND rates constrained by proportionality; AUTOMOTIVE: automotive component patents: 0.5-3%; manufacturing process patents: 0.5-2%; ENERGY AND CLEANTECH: renewable energy: 1-5%; process patents: 1-3%; UNIVERSITY TECHNOLOGY TRANSFER: median exclusive license royalty rate: 3-4% (AUTM survey); typical upfront fee: $10K-$100K; milestone payments: $100K-$5M+; FACTORS AFFECTING RATES ABOVE OR BELOW BENCHMARKS: strength and breadth of patent claims; exclusivity; remaining patent term; availability of alternatives; profit margins of licensee; competitive landscape; whether licensor also competes.

FRAND (Fair, Reasonable, and Non-Discriminatory) licensing applies to standard-essential patents: WHAT ARE SEPs: standard-essential patents are patents that must be practiced to implement a technical standard (Wi-Fi, LTE, 5G, HEVC, USB, Bluetooth); if a patent is truly essential, there is NO non-infringing alternative — you must use it to implement the standard; FRAND COMMITMENT: when standards bodies (IEEE, ETSI, 3GPP) develop standards, they require patent holders to commit to licensing on FRAND terms; this prevents patent holdup — leveraging standards inclusion to extract supra-competitive royalties; FRAND DOES NOT MEAN FREE: FRAND requires fair compensation; FRAND does not require the lowest possible royalty; FRAND royalties are still typically paid FRAND royalties can range from small fractions of 1% to several percent depending on the technology; FRAND RATE DETERMINATION METHODS: (a) TOP-DOWN: calculate total FRAND royalty burden for an entire standard; divide by number of essential patents; allocate to specific patent families based on contribution; prevents royalty stacking; (b) COMPARABLE LICENSES: use actual licenses for comparable SEPs as evidence of market-clearing FRAND rates; licenses must be comparable: similar technology; similar geographic scope; similar time period; (c) COST-PLUS / VALUE-BASED: calculate rate based on value of contribution to standard; FRAND LITIGATION: Ericsson v. D-Link Systems (Fed. Cir. 2014): FRAND royalty must apportion value to patented technology, not entire standard-implementing product; must account for royalty stacking; TCL Communication v. Ericsson (C.D. Cal. 2018): court-set FRAND rate for 4G LTE portfolios; Microsoft v. Motorola (W.D. Wash. 2013): FRAND rates set by court for H.264 and Wi-Fi patents; WILLING LICENSEE: FRAND requires the patent owner to license to any willing licensee; an unwilling licensee (refusing to pay) may not receive FRAND protection.

Patent license negotiation involves multiple financial and legal terms beyond the royalty rate: LICENSE SCOPE: (a) EXCLUSIVITY: exclusive license (only licensee can practice); exclusive field-of-use license (exclusive in defined fields); non-exclusive license (licensor can license to others); (b) FIELD OF USE: limits license to specific applications, markets, or industries; allows licensor to license the same patent to non-competing parties; (c) TERRITORY: geographic limits; worldwide vs. specific countries; (d) SUBLICENSING: whether licensee can grant sublicenses; if yes, headlicense royalty sharing (25-50%) typically required; LICENSE TERM: limited to patent term; renewable; evergreen with termination rights; ROYALTY BASE DEFINITION: 'net sales' definition is heavily negotiated; deductions allowed: returns, discounts, allowances, freight, insurance, taxes; 'transfer price' rules for sales to affiliates (arms-length pricing); AUDIT RIGHTS: licensor typically gets right to audit licensee's books; 1-3 years of records; costs paid by licensor unless discrepancy found (>X%); MOST-FAVORED-NATION (MFN) CLAUSE: if licensor grants better rates to another licensee, the original licensee gets the better rate; controversial — licensor argues limits flexibility; REPORTING: quarterly royalty reports + payments; annual reconciliation; MINIMUM ROYALTIES: guaranteed minimum payments regardless of usage; if minimums not met, termination right or conversion to non-exclusive; MILESTONE PAYMENT SCHEDULE: specific triggering events; cure periods for missed milestones; IMPROVEMENTS: who owns improvements to the licensed technology? grant-back provisions (licensee grants back license on improvements); TERMINATION: for breach (with cure period); for insolvency; for challenge to patent validity (anti-challenge clauses — enforceability varies by jurisdiction); INDEMNIFICATION: who bears risk if a third party claims the licensed technology infringes their patent?

Royalty stacking occurs when multiple patent owners each charge royalties on the same product: THE STACKING PROBLEM: a modern smartphone implements hundreds of patents owned by dozens of companies; if each patent owner charges 1-5% of product price, combined royalties could exceed 100% of product value; royalty stacking makes multi-patent industries unworkable if each licensor ignores the cumulative burden; TYPICAL STACKING CONTEXTS: smartphones: video codecs + wireless standards + Bluetooth + GPS + interface patents; software platforms: dozens of patents from multiple owners; automotive: infotainment + ADAS + powertrain patents; LEGAL TREATMENT OF STACKING: Ericsson v. D-Link (Fed. Cir. 2014): when calculating FRAND rates for SEPs, courts must account for royalty stacking; expert testimony on aggregate royalty burden is required; top-down approach accounts for stacking by dividing total available royalty among all essential patents; NON-SEP STACKING: for non-standard-essential patents, courts generally do not require explicit stacking analysis; however, parties in litigation present stacking evidence to counter unreasonably high royalty demands; PATENT POOLS: one solution to stacking; multiple patent owners pool their patents and offer a single license covering all pooled patents; examples: MPEG LA pool for MPEG-2, H.264, HEVC, VVC; Via Licensing for audio codecs; Avanci for IoT/automotive cellular; PATENT POOL BENEFITS: single license covers all pooled patents; often lower aggregate rates; reduces transaction costs; PATENT POOL RISKS: antitrust concerns if pool is used to coordinate pricing; must include only truly essential patents; must be open to all on FRAND-equivalent terms; DESIGN-AROUND AS STACKING RESPONSE: when stacking makes licensing uneconomical, companies may invest in designing around some patents to reduce the total royalty burden; PORTFOLIO CROSS-LICENSING: large companies often cross-license entire portfolios to zero out royalty obligations; creates barriers to entry for patent-poor startups.